HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

摘要

The present disclosure relates to compounds of Formula 1 as human protein tyrosine phosphatase beta (HPTP-P) inhibitors thereby regulating angiogenesis: (see formula 1) The present disclosure further relates to compositions comprising one or more of the human protein tyrosine phosphatase beta (HPTP-.beta.) inhibitors of Formula 1, and to methods for regulating angiogenesis.